Brightsurf Science News & Current Events

December 09, 2005
Patients who trust their doctors more have better outcomes
Patients with higher levels of trust in their regular physicians are more likely than patients with less trust to have better care, a new study finds.

Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
Researchers today presented preliminary safety and efficacy data for E7389 in the treatment of advanced, refractory breast cancer during the San Antonio Breast Cancer Symposium.

More funding needed to fight Australia's biggest killer
The need to increase support for health and medical research in Australia has been highlighted this week by the lack of funds for a major new initiative to address the causes of heart disease - Australia's biggest killer.

Cell phones, driving don't mix
When it comes to more complicated

Memorial symposium scheduled at Yale to honor D. Allan Bromley
A Memorial Symposium in honor of the late physicist D.

Pramipexole delivered sustained efficacy in clinical trial of patients with Restless Legs Syndrome
Two large, randomised, placebo-controlled studies presented at the inaugural conference of the World Association of Sleep Medicine (WASM; Berlin, Germany) in October demonstrate that pramipexole delivered both short-term and sustained efficacy in patients suffering from Restless Legs Syndrome (RLS).

Medical College of Wisconsin researchers
Researchers at the Medical College of Wisconsin in Milwaukee in collaboration with a national team have developed a biodefense cocktail which activates the immune system against a broad range of viruses and bacteria.

How the neuron sprouts its branches
Neurobiologists have gained new insights into how neurons control growth of the intricate tracery of branches called dendrites that enable them to connect with their neighbors.

Study shows combination of immune substances to be safe
New research has shown that the immune-stimulating hormone known as interleukin-12 (IL-12) can safely be administered with interferon, another immune-system protein, as an experimental therapy for some cancers.

JHU-STScI team maps dark matter in startling detail
Clues revealed by the recently sharpened view of the Hubble Space Telescope have allowed astronomers to map the location of invisible

New, unique microscope for nanotech
UC Davis researchers in nanotechnology, chemistry and biology now have access to one of the most advanced microscopes of its type in the world.

Researchers: More women physicians likely to choose pediatric subspecialties
Concerns among health care analysts that the majority of pediatricians in training are now women and that that might cause shortages in the future in pediatric subspecialties appear to be almost entirely unfounded, a new University of North Carolina at Chapel Hill study concludes.

Glacial pace of erosion was not so slow, new technique shows
Glaciers, rivers and shifting tectonic plates have shaped mountains over millions of years, but earth scientists have struggled to understand the relative roles of these forces and the rates at which they work.

Ownership of Southern forestland dramatically changing
Two new research studies document dramatic changes in the ownership of Southern forestland and declining markets for its forest products.

Leibniz Prize winners 2006
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has announced the winners of its 2006 Gottfried Wilhelm Leibniz Prize.

New models of weather pattern
For a mathematician, Joseph Biello spends a lot of time thinking about the weather.

UT Southwestern scientist receives international award for pediatric research
Dr. Eric Olson, chairman of molecular biology at UT Southwestern Medical Center, has won the fourth annual Pollin Prize in Pediatric Research, a lifetime achievement award.

Magnet lab researcher exploring science behind commercial applications of liquid helium
Unlocking the mystery of how to manipulate, measure and separate very tiny particles has tremendous applications for the pharmaceutical industry and could change how some medications are delivered and how effective they are.

New data suggest pramipexole relieves symptoms of Restless Legs Syndrome (RLS) and is well-tolerated
New data, reported for the first time at this year's European Federation of Neurological Societies (EFNS) Annual Meeting in Athens, Greece, support the efficacy and safety of Boehringer Ingelheim's dopamine agonist pramipexole in treating patients with Restless Legs Syndrome (RLS).

IPv6 transition should be part of national innovation debate says IEEE-USA President Gerry Alphonse
In a keynote address delivered this morning to the US IPv6 Summit in Reston, Va., IEEE-USA President Gerard A.

Movement of North Magnetic Pole is accelerating
After some 400 years of relative stability, Earth's North Magnetic Pole has moved nearly 1,100 kilometers out into the Arctic Ocean during the last century and at its present rate could move from northern Canada to Siberia within the next half-century.

Mayo Clinic Cancer Center reports advancements and solutions for quality of life assessments
Mayo Clinic Cancer Center researchers recently published the first series of chapters in a two-part monograph discussing quality of life (QOL) assessment -- best practices, promising techniques and revolutionary applications.

Taxpayer advocacy group says Cures Bill is the right medicine
The Alliance for Taxpayer Access (ATA), a national coalition of patient groups, libraries, and public interest organizations, today praised the research access provision of legislation introduced to establish the American Center for Cures within the National Institutes of Health (NIH).

Norway signs bilateral agreement on science and technology with the United States
Norway will enter into a bilateral agreement on science and technology with the United States.

Mayo Clinic researchers find hole in heart does not make stroke inevitable
Mayo Clinic researchers have found that -- contrary to current thinking by some in the medical community -- a patent foramen ovale (PFO), a small hole between the two upper chambers of the heart, does not predestine an individual to a stroke later in life. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to